Evidence map›Paper›PMID 24755692›Full record

ArticlePloS one2014

Targeted NGF siRNA delivery attenuates sympathetic nerve sprouting and deteriorates cardiac dysfunction in rats with myocardial infarction.

Hesheng Hu, Yongli Xuan, Ye Wang, Mei Xue, Fei Suo, Xiaolu Li, Wenjuan Cheng, Xinran Li, Jie Yin, Ju Liu and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Primary Mechanism Study ofCardiology research and practice · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. P2XJournal of cellular and molecular medicine · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Hesheng HuSchool of Medicine, Shandong University, Jinan, China; Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Yongli XuanSchool of Medicine, Shandong University, Jinan, China.
Ye WangDepartment of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Mei XueDepartment of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Fei SuoSchool of Medicine, Shandong University, Jinan, China; Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Xiaolu LiDepartment of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Wenjuan ChengSchool of Medicine, Shandong University, Jinan, China; Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Xinran LiSchool of Medicine, Shandong University, Jinan, China.
Jie YinSchool of Medicine, Shandong University, Jinan, China.
Ju LiuMedical Research Center, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Suhua YanDepartment of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
Shandong University · CNShandong Provincial QianFoShan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nerve growth factor (NGF) is involved in nerve sprouting, hyper-innervation, angiogenesis, anti-apoptosis, and preservation of cardiac function after myocardial infarction (MI). Positively modulating NGF expression may represent a novel pharmacological strategy to improve post-infarction prognosis. In this study, lentivirus encoding NGF short interfering RNA (siRNA) was prepared, and MI was modeled in the rat using left anterior descending coronary artery ligation. Rats were randomly grouped to receive intramyocardial injection of lentiviral solution containing NGF-siRNA (n = 19, MI-SiNGF group), lentiviral solution containing empty vector (n = 18, MI-GFP group) or 0.9% NaCl solution (n = 18, MI-control group), or to receive thoracotomy and pericardiotomy (n = 17, sham-operated group). At 1, 2, 4, and 8 wk after transduction, rats in the MI-control group had higher levels of NGF mRNA and protein than those in the sham-operated group, rats in the MI-GFP group showed similar levels as the MI-control group, and rats in the MI-SiNGF group had lower levels compared to the MI-GFP group, indicating that MI model was successfully established and NGF siRNA effectively inhibited the expression of NGF. At 8 wk, echocardiographic and hemodynamic studies revealed a more severe cardiac dysfunction in the MI-siRNA group compared to the MI-GFP group. Moreover, rats in the MI-siRNA group had lower mRNA and protein expression levels of tyrosine hydroxylase (TH) and growth-associated protein 43-positive nerve fibers (GAP-43) at both the infarcted border and within the non-infarcted left ventricles (LV). NGF silencing also reduced the vascular endothelial growth factor (VEGF) expression and decreased the arteriolar and capillary densities at the infarcted border compared to the MI-GFP group. Histological analysis indicated a large infarcted size in the MI-SiNGF group. These findings suggested that endogenous NGF silencing attenuated sympathetic nerve sprouting and angiogenesis, enlarged the infarct size, aggravated cardiac dysfunction, and potentially contributed to an unfavorable prognosis after MI.

Indexed as

Transduction, GeneticAnimalsGAP-43 ProteinGene SilencingHemodynamicsLentivirusMaleMicrovesselsMyocardial InfarctionNeovascularization, PathologicNerve Growth FactorPlatelet Endothelial Cell Adhesion Molecule-1Rats, WistarRNA, Small InterferingSympathetic Nervous SystemUltrasonographyGAP-43 ProteinNerve Growth FactorPlatelet Endothelial Cell Adhesion Molecule-1RNA, Small InterferingVascular Endothelial Growth Factor A

Identifiers

PMID24755692
PMCPMC3995702
OpenAlexW1973359665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.